Clinical trial
European Study of HF0220 in Mild to Moderate Alzheimer's Disease Patients
NCT00357357 · Hunter-Fleming Ltd, Industry · Completed
Key facts
| NCT number | NCT00357357 |
|---|---|
| Title | European Study of HF0220 in Mild to Moderate Alzheimer's Disease Patients |
| Official title | Clinical Safety/Tolerability of HF0220 and Its Effect on Biochemical Markers Relevant to Patients With a Diagnosis of Mild to Moderate Alzheimer' Disease |
| Lead sponsor | Hunter-Fleming Ltd, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Alzheimer's Disease |
| Intervention type | Drug |
| Interventions | HF0220 |
| Enrollment | 40 |
| Start date | Jul 1, 2006 |
| Primary completion | Aug 1, 2008 |
| Completion | Aug 1, 2008 |
| First posted | Jul 27, 2006 |
| Last update posted | Aug 21, 2008 |
| Countries | India, Sweden, United Kingdom |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: